SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that Michael Morrissey, Ph.D., the company’s president and chief executive officer, will present at the upcoming Deutsche Bank Securities Health Care Conference at 12:55 p.m. EDT / 9:55 a.m. PDT on Wednesday, May 4, 2011 in Boston. During the presentation, Dr. Morrissey will review the most recent publicly available data for cabozantinib in castration-resistant prostate cancer (CRPC) and discuss the pivotal trial plans and regulatory strategy for the compound in CRPC. He will also discuss the company’s 2011 financial outlook and provide a general business update.
